Proteomics in pancreatic disease

Pancreatology

Volumn 4, Issue 2, 2004, Pages 67-75

  Löhr, Matthias ^a   Faissner, Ralf ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Pancreas; Pancreatic carcinoma; Pancreatitis; Pancreatology; Proteome; Proteomics; Review

Indexed keywords

CELL PROTEIN; GENOMIC DNA; PROTEOME;

DNA DETERMINATION; GENOMICS; HUMAN; MASS SPECTROMETRY; METHODOLOGY; PANCREAS DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; RNA ANALYSIS; RNA TRANSCRIPTION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 2942709652     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000077212     Document Type: Article

References (103)

1. Anderson NL, Anderson NG: Proteome and proteomics: New technologies, new concepts, and new words. Electrophoresis 1998;19:1853-1861.
2. Pociot F, Karlsen AE: Combined genome and proteome approach to identify new susceptibility genes. Am J Med Genet 2002;115:55-60.
3. Zhang W, Wang H, Song SW, Fuller GG: Insulin-like growth factor binding protein 2: Gene expression microarrays and the hypothesis generation paradigm. Brain Pathol 2002;12:87-94.
4. Liang M, Cowley AW Jr, Greene AS: High throughput gene expression profiling: A molecular approach to integrative physiology. J Physiol 2003;epublish ahead of print.
5. Kettman JR, Coleclough C, Frey JR, Lefkovits I: Clonal proteomics: One gene - family of proteins. Proteomics 2002;2:624-631.
6. Sinha P, Hütter G, Kottgen E, Dietel M, Schadendorf D, Lage H: Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. Electrophoresis 1999;20:2952-2960.
7. Lottspeich F: Proteome analysis: A pathway to the functional analysis of proteins. Angew Chem Int Ed Engl 1999;38:2476-2492.
8. Graves PR, Haystead TA: Molecular biologist's guide to proteomics. Microbiol Mol Biol Rev 2002;66:39-63.
9. Rabilloud T: Two-dimensional gel electrophoresis in proteomics: Old, old fashioned, but it still climbs up the mountains. Proteomics 2002;2:3-10.
10. Righetti PG, Castagna A, Antonucci F, Piubelli C, Cecconi D, Campostrini N, et al: The proteome: Anno Domini 2002. Clin Chem Lab Med 2003;41:425-438.
11. Phizicky E, Bastiaens PIH, Zhu H, Snyder M, Fields S: Protein analysis on a proteomic scale. Nature 2003;422:208-215.
12. Blackstock WP, Weir MP: Proteomics: Quantitative and physical mapping of cellular proteins. Trends Biotechnol 1999;17:121-127.
13. Hanash S: Disease proteomics. Nature 2003;422:226-232.
14. Hütter G, Sinha P: Proteomics for studying cancer cells and the development of chemoresistance. Proteomics 2001;1:1233-1248.
15. Wulfkuhle JD, Liotta LA, Petricoin EF: Proteomic applications for the early detection of cancer. Nat Rev Cancer 2003;3:267-275.
16. Chambers G, Lawrie L, Cash P, Murray GI: Proteomics: a new approach to the study of disease. J Pathol 2000;192:280-288.
17. Dunn MJ: Studying heart disease using the proteomic approach. Drug Discov Today 2000;5:76-84.
18. Van Eyk JE: Proteomics: Unraveling the complexity of heart disease and striving to change cardiology. Curr Opin Mol Ther 2001;3:546-553.
19. Hanash SM, Bobek MP, Rickman DS, Williams T, Rouillard JM, Kuick R, et al: Integrating cancer genomics and proteomics in the post-genome era. Proteomics 2002;2:69-75.
20. Hanash SM, Madoz-Gurpide J, Misek DE: Identification of novel targets for cancer therapy using expression proteomics. Leukemia 2002;16:478-485.
21. Corthals GL, Wasinger VC, Hochstrasser DF, Sanchez JC: The dynamic range of protein expression: A challenge for proteomic research. Electrophoresis 2000;21:1104-1115.
22. Dua K, Williams TM, Beretta L: Translational control of the proteome: Relevance to cancer. Proteomics 2001;1:1191-1199.
23. Buchholz M, Boeck W, Fensterer H, Muller F, Wenger C, Michl P, et al: Use of DNA arrays/microarrays in pancreatic research. Pancreatology 2001;1:581-586.
24. Wandschneider S, Fehring V, Jacobs-Emeis S, Thiesen HJ, Löhr M: Autoimmune pancreatic disease: Preparation of pancreatic juice for proteome analysis. Electrophoresis 2001;22:4383-4390.
25. Sparmann G, Jäschke A, Müller P, Löhr M, Liebe S, Emmrich J: Tissue homogenization as a key step extracting RNA from human and rat pancreatic tissue. Biotechniques 1997;22:408-412.
26. Müller P, Jesnowski R, Liebe S, Rolfs A, Löhr M: Simple method for DNA extraction from pancreatic juice for PCR amplification assays. Int J Pancreatol 1999;25:39-43.
27. O'Farrell PH: High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975;250:4007-4021.
28. Klose J: Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik 1975;26:231-243.
29. Scheele GA: Two-dimensional gel analysis of soluble proteins. Characterization of guinea pig exocrine pancreatic proteins. J Biol Chem 1975;250:5375-5385.
30. Scheele GA, Palade GE: Studies on the guinea pig pancreas: Parallel discharge of exocrine enzyme activities. J Biol Chem 1975;250:2660-2670.
31. Santoni V, Molloy M, Rabilloud T: Membrane proteins and proteomics: Un amour impossible? Electrophoresis 2000;21:1054-1070.
32. Harry JL, Wilkins MR, Herbert BR, Packer NH, Gooley AA, Williams KL: Proteomics: Capacity versus utility. Electrophoresis 2000;21:1071-1081.
33. Herbert B, Righetti PG: A turning point in proteome analysis: Sample prefractionation via multicompartment electrolyzers with isoelectric membranes. Electrophoresis 2000;21:3639-3648.
34. Neuhoff V, Arold N, Taube D, Ehrhardt W: Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 1988;9:255-262.
35. Merril CR, Switzer RC, Van Keuren ML: Trace polypeptides in cellular extracts and human body fluids detected by two-dimensional electrophoresis and a highly sensitive silver stain. Proc Natl Acad Sci USA 1979;76:4335-4339.
36. Blum H, Gross HJ, Beier H: The expression of the TMV-specific 30-kDa protein in tobacco protoplasts is strongly and selectively enhanced by actinomycin. Virology 1989;169:51-61.
37. Zhan X, Desiderio DM: Differences in the spatial and quantitative reproducibility between two second-dimensional gel electrophoresis systems. Electrophoresis 2003;24:1818-1833.
38. Anderson NG, Anderson NL: Twenty years of two-dimensional electrophoresis: Past, present and future. Electrophoresis 1996;17:443-453.
39. Patterson SD, Aebersold RH: Proteomics: the first decade and beyond. Nat Genet Suppl 2003;33:311-323.
40. Bjellqvist B, Ek K, Righetti PG, Gianazza E, Görg A, Westermeier R, et al: Isoelectric focusing in immobilized pH gradients: Principle, methodology and some applications. J Biochem Biophys Methods 1982;6:317-339.
41. Bjellqvist B, Pasquali C, Ravier F, Sanchez JC, Hochstrasser D: A nonlinear wide-range immobilized pH gradient for two-dimensional electrophoresis and its definition in a relevant pH scale. Electrophoresis 1993;14:1357-1365.
42. Görg A, Obermaier C, Boguth G, Harder A, Scheibe B, Wildgruber R, et al: The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000;21:1037-1053.
43. Shevchenko A, Wilm M, Vorm O, Mann M: Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996;68:850-858.
44. Yan JX, Wait R, Berkelman T, Harry RA, Westbrook JA, Wheeler CH, et al: A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 2000;21:3666-3672.
45. Steinberg TH, Lauber WM, Berggren K, Kemper C, Yue S, Patton WF: Fluorescence detection of proteins in sodium dodecyl sulfate-polyacrylamide gels using environmentally benign, nonfixative, saline solution. Electrophoresis 2000;21:497-508.
46. Patton WF: Detection technologies in proteome analysis. J Chromatogr B Analyt Technol Biomed Life Sci 2002;771:3-31.
47. Fehring V, Wandschneider S, Löhr M: Physical markers for landmarking fluorescently stained gels that facilitate automated spot-picking. Electrophoresis 2001;22:2903-2907.
48. Hoving S, Voshol H, van Oostrum J: Towards high performance two-dimensional gel electrophoresis using ultrazoom gels. Electrophoresis 2000;21:2617-2621.
49. Zuo X, Speicher DW: Comprehensive analysis of complex proteomes using microscale solution isoelectrofocusing prior to narrow pH range two-dimensional electrophoresis. Proteomics 2002;2:58-68.
50. Sanchez JC, Rouge V, Pisteur M, Ravier F, Tonella L, Moosmayer M, et al: Improved and simplified in-gel sample application using reswelling of dry immobilized pH gradients. Electrophoresis 1997;18:324-327.
51. Vandekerckhove J, Bauw G, Puype M, Van Damme J, Van Montagu M: Protein-blotting on polybrene-coated glass-fiber sheets. A basis for acid hydrolysis and gas-phase sequencing of picomole quantities of protein previously separated on sodium dodecyl sulfate/polyacrylamide gel. Eur J Biochem 1985;152:9-19.
52. Aebersold RH, Teplow DB, Hood LE, Kent SB: Electroblotting onto activated glass. High efficiency preparation of proteins from analytical sodium dodecyl sulfate-polyacrylamide gels for direct sequence analysis. J Biol Chem 1986;261:4229-4238.
53. Aebersold R, Mann M: Mass spectrometry-based proteomics. Nature 2003;422:198-207.
54. Karas M, Hillenkamp F: Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem 1988;60:2299-2301.
55. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM: Electrospray ionization for mass spectrometry of large biomolecules. Science 1989;246:64-71.
56. Eckerskorn C, Strupat K, Karas M, Hillenkamp F, Lottspeich F: Mass spectrometric analysis of blotted proteins after gel electrophoretic separation by matrix-assisted laser desorption/ionization. Electrophoresis 1992;13:664-665.
57. Wilkins MR, Gasteiger E, Bairoch A, Sanchez JC, Williams KL, Appel RD, et al: Protein identification and analysis tools in the ExPASy server. Methods Mol Biol 1999;112:531-552.
58. Clauser KR, Baker P, Burlingame AL: Role of accurate mass measurement (± 10 ppm) in protein identification strategies employing MS or MS/MS and database searching. Anal Chem 1999;71:2871-2882.
59. Zhang W, Chait BT: ProFound: an expert system for protein identification using mass spectrometric peptide mapping information. Anal Chem 2000;72:2482-2489.
60. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS: Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999;20:3551-3567.
61. Göke B, Keim V, Dagorn JC, Arnold R, Adler G: Resolution of human exocrine pancreatic juice proteins by reversed- phase high performance liquid chromatography (HPLC). Pancreas 1990;5:261-266.
62. Keim V, Iovanna JL, Rohr G, Usadel KH, Dagorn JC: Characterization of a rat pancreatic secretory protein associated with pancreatitis. Gastroenterology 1991;100:775-782.
63. Rausch U, Weidenbach H, Adler G, Kern HF: Stimulation of pancreatic secretory process in the rat by low-molecular weight proteinase inhibitor. II. Regulation of total protein and individual enzyme biosynthesis. Cell Tissue Res 1987;249:63-67.
64. Van Nest GA, MacDonald RJ, Raman RK, Rutter WJ: Proteins synthesized and secreted during rat pancreatic development. J Cell Biol 1980;86:784-794.
65. Moll R, Franke WW: Cytoskeletal differences between human neuroendocrine tumors: A cytoskeletal protein of molecular weight 46,000 distinguishes cutaneous from pulmonary neuroendocrine neoplasms. Differentiation 1985;30:165-175.
66. Herzig KH, Altmannsberger M, Fölsch UR: Intermediate filaments in rat pancreatic acinar tumors, human ductal carcinomas, and other gastrointestinal malignancies. Gastroenterology 1994;106:1326-1332.
67. Schneider MU, Rösch W, Domschke S, Domschke W: Pancreatic juice protein associated with chronic pancreatitis and adenocarcinoma of the pancreas. Scand J Gastroenterol 1984;19:139-144.
68. Reeve JR Jr, McVey DC, Bunnett NW, Solomon TE, Keire DA, Ho FJ, et al: Differences in receptor binding and stability to enzymatic digestion between CCK-8 and CCK-58. Pancreas 2002;25:50-55.
69. Basso D, Valerio A, Seraglia R, Mazza S, Piva MG, Greco E, et al: Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide. Pancreas 2002;24:8-14.
70. Graf R, Schiesser M, Bimmler D: Increased secretion of the pancreatic secretory trypsin inhibitor (PSTI- I, monitor peptide) during development of chronic pancreatitis in the WBN/Kob rat. Pancreatology 2002;2:108-115.
71. Cerini C, Peyrot V, Garnier C, Duplan L, Veesler S, Le Caer JP, et al: Biophysical characterization of lithostathine. Evidences for a polymeric structure at physiological pH and a proteolysis mechanism leading to the formation of fibrils. J Biol Chem 1999;274:22266-22274.
72. Larsen PM, Fey SJ, Larsen MR, Nawrocki A, Andersen HU, Kahler H, et al: Proteome analysis of interleukin-1beta-induced changes in protein expression in rat islets of Langerhans. Diabetes 2001;50:1056-1063.
73. Sanchez JC, Converset V, Nolan A, Schmid G, Wang S, Heller M, et al: Effect of rosiglitazone on the differential expression of diabetes-associated proteins in pancreatic islets of C57Bl/6 lep/lep mice. Mol Cell Proteomics 2002;1:509-516.
74. Klöppel G, Lüttges J, Zamboni G, Löhr M, Longnecker DS: Autoimmune pancreatitis: Pathological, clinical and immunological features. Pancreas 2003;27:14-19.
75. Wandschneider S, Löhr M: Protein analysis of pancreatic tissue with autoimmune pancreatitis (abstract). Pancreatology 2002;2:234.
76. Shekouh AR, Thompson CCM, Pennington SR, Hamlett J, Herrington S, Prime W, et al: Protein expression profiling of normal and malignant pancreatic duct cells (abstract). Pancreatology 2002;2:256.
77. Naour FL, Brichory F, Beretta L, Hanash SM: Identification of tumor-associated antigens using proteomics. Technol Cancer Res Treat 2002;1:257-262.
78. Möller A, Soldan M, Völker U, Maser E: Two-dimensional gel electrophoresis: A powerful method to elucidate cellular responses to toxic compounds. Toxicology 2001;160:129-138.
79. Möller A, Malerczyk C, Völker U, Stöppler H, Maser E: Monitoring daunorubicin-induced alterations in protein expression in pancreas carcinoma cells by two-dimensional gel electrophoresis. Proteomics 2002;2:697-705.
80. Poland J, Schadendorf D, Lage H, Schnölzer M, Celis JE, Sinha P: Study of therapy resistance in cancer cells with functional proteome analysis. Clin Chem Lab Med 2002;40:221-234.
81. Cecconi D, Scarpa A, Donadelli M, Palmieri M, Hamdan M, Astner H, Righetti PG: Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A. Electrophoresis 2003;24:1871-1878.
82. Choong ML, Tan LK, Lo SL, Ren EC, Ou K, Ong SE, et al: An integrated approach in the discovery and characterization of a novel nuclear protein over-expressed in liver and pancreatic tumors. FEBS Lett 2001;496:109-116.
83. Simone NL, Paweletz CP, Charboneau L, Petricoin EF 3rd, Liotta LA: Laser capture microdissection: beyond functional genomics to proteomics. Mol Diagn 2000;5:301-307.
84. Craven RA, Banks RE: Laser capture microdissection and proteomics: Possibilities and limitation. Proteomics 2001;1:1200-1204.
85. Celis JE, Celis P, Ostergaard M, Basse B, Lauridsen JB, Ratz G, et al: Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: A novel strategy for identifying metaplastic lesions. Cancer Res 1999;59:3003-3009.
86. Abbott A: The society of proteins. Nature 2002;417:894-896.
87. Cutler P: Protein arrays: The current state-of-the-art. Proteomics 2003;3:3-18.
88. Merchant M, Weinberger SR: Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 2000;21:1164-1177.
89. Wright GL Jr: SELDI proteinchip MS: A platform for biomarker discovery and cancer diagnosis. Expert Rev Mol Diagn 2002;2:549-563.
90. Issaq HJ, Conrads TP, Prieto DA, Tirumalai R, Veenstra TD: SELDI-TOF MS for diagnostic proteomics. Anal Chem 2003;75:148A-155A.
91. Rosty C, Christa L, Kuzdzal S, Baldwin WM, Zahurak ML, Carnot F, et al: Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology. Cancer Res 2002;62:1868-1875.
92. Wapnir IL, van de Rijn M, Nowels K, Amenta PS, Walton K, Montgomery K, et al: Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J Clin Endocrinol Metab 2003;88:1880-1888.
93. Ji B, Chen XQ, Misek DE, Kuick R, Hanash S, Ernst S, et al: Pancreatic gene expression during the Initiation of acute pancreatitis: Identification of EGR-1 as a key regulator. Physiol Genomics 2003;14:59-72.
94. Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Kochli OR, et al: Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001;159:2249-2256.
95. Berrar D, Dubitzky W, Solinas-Toldo S, Bulashevska S, Granzow M, Conrad C, et al: A database system for comparative genomic hybridization analysis. IEEE Eng Med Biol Mag 2001;20:75-83.
96. Wiemer J, Schubert F, Granzow M, Ragg T, Fieres J, Mattes J, et al: Informatics united: Exemplary studies combining medical informatics, neuroinformatics and bioinformatics. Methods Inf Med 2003;42:126-133.
97. Choudhary JS, Blackstock WP, Creasy DM, Cottrell JS: Interrogating the human genome using uninterpreted mass spectrometry data. Proteomics 2001;1:651-667.
98. Ma B, Tromp J, Li M: PatternHunter: Faster and more sensitive homology search. Bioinformatics 2002;18:440-445.
99. Taylor CF, Paton NW, Garwood KL, Kirby PD, Stead DA, Yin Z, et al: A systematic approach to modeling, capturing, and disseminating proteomics experimental data. Nat Biotechnol 2003;21:247-254.
100. Wolkenhauer O: Systems biology: The reincarnation of systems theory applied in biology? Brief Bioinform 2001;2:258-270.
101. Gerlich D, Beaudouin J, Gebhard M, Ellenberg J, Eils R: Four-dimensional imaging and quantitative reconstruction to analyse complex spatiotemporal processes in live cells. Nat Cell Biol 2001;3:852-855.
102. Huang E, Ishida S, Pittman J, Dressman H, Bild A, Kloos M, et al: Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat Genet 2003;34:226-230.
103. Katoh M: Paradigm shift in gene-finding method: From bench-top approach to desktop approach (review). Int J Mol Med 2002;10:677-682.